News | Women's Health | May 11, 2017

3-D Mammography Changing the Face of Cancer Screening and Treatment

Global market research gives insight to the competitive mammography landscape

mammography exam

Photo courtesy of Hologic

Breast cancer is one of the leading causes of death of women worldwide. In Canada, according to the Canadian Cancer Society, one in every nine women is expected to develop breast cancer in her lifetime, and one in thirty will die from it. Though breast cancer rates were high relatively high in the 1990s, they decreased in the 2000s—and continue to remain much lower than they were in the 80s and 90s—thanks to the increased use of mammography. Mammography can detect early breast cancer in women experiencing no symptoms and is an essential tool and lifesaving measure. According to Infiniti Research, the global market for mammography devices and equipment will grow at a rate of more than 9 percent until 2020.

Infiniti Research has recently completed a market assessment on the mammography device market for a leading global manufacturer and supplier of diagnostic products, medical imaging systems, and surgical products. The purpose of this study was to help the client assess and analyze the competitive landscape for mammography devices.

 

Market Trends

Though 2-D mammography has long been an effective and affordable industry standard, 3-D mammography is becoming more popular. While 2-D mammography captures two static images of the breast, 3-D mammography takes multiple images of the breast, allowing for a more comprehensive and accurate picture, and reducing the risk of missing abnormalities due to image overlap. However, the benefits of 3-D mammography over 2-D have yet to be fully proven, and 3-D mammography is more expensive for uninsured patients. Another popular method involves combining 2-D and 3-D mammography, though this is currently very new. Some studies have suggested that 3-D mammography puts the patient at a higher risk for cancer from radiation, though this has not yet been confirmed.

 

Market Opportunities

Because the use of 3-D and combination 2-D and 3-D mammography is still relatively new and the risks associated with it are still largely unknown or unconfirmed, market intelligence is critical for vendors looking to enter this market. To keep their patients safe and establish themselves as reliable, vendors need to be up-to-date on market trends and developments, medical advancements and challenges, and how breast cancer incidence and treatment differs around the world.

In their latest assessment of the global mammography device market, Infiniti’s market intelligence analysts helped their client, a leading global manufacturer and supplier of diagnostic products, to gain an in-depth understanding of how the competitive landscape for mammography devices and equipment differed across the world, with special focus on target countries including the US, Germany, China, Great Britain, Australia, and France. Infiniti’s analysts researched and monitored the latest developments in the market through journals and whitepapers, and also conducted extensive interviews with stakeholders such as channel partners, business executives, and suppliers in order to develop a holistic overview of the market scenario.

 

You can view the complete study here: https://www.infinitiresearch.com/casestudy/competitive-intelligence-assessment-mammography-devices

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing
iCAD ProFound AI

Image courtesy of iCAD

News | Breast Imaging | June 25, 2019
Use of...